Skip to content
DraconiticResearch
Search Sources API
197,785 studies31 sourcesUpdated 44 min ago
Peer-reviewedLicence not statedDiabetes care

Comparative Short-Term Risk of Severe Gastrointestinal Events Associated with Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

  • Sungho Bea1
  • Elisabetta Patorno1,2
  • Sushama Kattinakere Sreedhara1
  • Deborah J. Wexler3
  • Sara J. Cromer3
  • Robert J. Glynn1
  • Julie M. Paik1,4,5
  • Katsiaryna Bykov1
5 affiliations
  1. 1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
  2. 2Division of General Internal Medicine & Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
  3. 3Diabetes Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  4. 4Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
  5. 5New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts
Read full textPDFDOICite

Related

  1. Longitudinal Association Between the Change in Serum Procollagen Type III N-Terminal Peptide (PIIINP) and Skeletal Muscle Loss in Patients with Gastrointestinal Cancer Receiving Chemotherapy: A Prospective Cohort Study
    Mehmet Erdinç Esenkaya, Özlem Özdemir, Mustafa Değirmenci +3
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  2. Prognostic value of scoring systems in geriatric patients receiving warfarin presenting with upper gastrointestinal bleeding
    Tufan Akin Giray, Ramazan Guven, Akkan Avci +22
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  3. Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa
    Julio Zúñiga Cisneros, Michael Camilleri, Madhusudan Grover
    Acta gastroenterologica LatinoamericanaPeer-reviewedCC BY-NC-SAFull textGeneral medicineEurope PMC
  4. Effects of Adding Blenderized Tube Feeds to Commercial Enteral Formulas on Gastrointestinal Symptoms in Adult Patients Receiving Enteral Nutrition.
    Athanasios Migdanis, Constantinos Giaginis, Ioanna Partsalaki +6
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. AI-assisted 3D thoracic body composition analysis identifies candidate imaging markers associated with overall survival in older patients with lung cancer receiving radiotherapy
    Saerom Sung, Hyun Joon Choi, Sangwoon Jeong +5
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{bea2026comparative,
  title = {{Comparative Short-Term Risk of Severe Gastrointestinal Events Associated with Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists}},
  author = {Sungho Bea and Elisabetta Patorno and Sushama Kattinakere Sreedhara and Deborah J. Wexler and Sara J. Cromer and Robert J. Glynn and Julie M. Paik and Katsiaryna Bykov},
  journal = {Diabetes care},
  year = {2026},
  month = nov,
  doi = {10.2337/dc26-0757},
  url = {https://doi.org/10.2337/dc26-0757},
}
RIS
TY  - JOUR
TI  - Comparative Short-Term Risk of Severe Gastrointestinal Events Associated with Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
AU  - Sungho Bea
AU  - Elisabetta Patorno
AU  - Sushama Kattinakere Sreedhara
AU  - Deborah J. Wexler
AU  - Sara J. Cromer
AU  - Robert J. Glynn
AU  - Julie M. Paik
AU  - Katsiaryna Bykov
PY  - 2026
DA  - 2026/11/01
JO  - Diabetes care
DO  - 10.2337/dc26-0757
UR  - https://doi.org/10.2337/dc26-0757
SN  - 0149-5992
SN  - 1935-5548
ER  -